Abstract
The term “immunoreceptor tyrosine-based inhibition motif” (ITIM) was coined after the term “immunoreceptor tyrosine-based activation motif” (ITAM) to designate molecular motifs that antagonize ITAM-dependent cell activation (Daëron et al. 1995a; D’Ambrosio et al. 1995). The concept of ITIM lies on the coexpression by single cells of “on” and “off” molecules which, when kept in close proximity, transduce intracellular signals that interfere with each other. On and off receptors can be constitutively associated at the cell membrane, such as B Cell receptors (BCR) and CD22 on B lymphocytes (Law et al. 1996) or high-affinity IgE receptors (FcɛRI) and mast cell-associated function antigen (MAFA) on mast cells (Guthmann et al. 1995); or they can be coaggregated by extracellular ligands. Thus, ITIM-bearing low-affinity receptors for IgG (FcγRIIB) and ITAM-bearing receptors are coaggregated by IgG antibodies or soluble immune complexes (Amigorena et al. 1992; Daëron et al. 1995b; Daëron et al. 1995a). Although the spatial relationship established between MHC class I-specific killer cell Ig-like receptors (KIRs) and receptors that trigger cytotoxicity (Moretta et al. 1997) is unclear, KIRs needed to be coligated with FcɛRI by the same soluble molecules in order to inhibit the activation of mast cells in a reconstitution model (Bléry et al. 1997). Following aggregation or coaggregation of the receptors, both ITAMs and ITIMs are tyrosyl phosphorylated by src family protein tyrosine kinases and, once phosphorylated, they recruit cytoplasmic molecules having SH2 domains (Cambier 1995; Burshtyn and Long 1997; Vivier and Daëron 1997).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Adachi T, Flaswinkel H, Yakura H, Reth M, Tsubata T (1998) The B cell surface protein CD72 recruits the tyrosine phosphatase SHP-1 upon tyrosine phosphorylation. J Immunol 160:4662–4665
Alley TL, Cooper MD, Chen M, Kubagawa H (1998) Genomic structure of PIR-B, the inhibitory member of the paired immunoglobulin-like receptor genes in mice. Tissue Antigens 51:224–231
Amigorena S, Bonnerot C, Choquet D, Fridman WH, Teillaud JL (1989) FcγRII expression in resting and activated B lymphocytes. Eur J Immunol 19:1379–1385
Amigorena S, Bonnerot C, Drake J, Choquet D, Hunziker W, Guillet JG, Webster P, Sautès C, Mellman I, Fridman WH (1992) Cytoplasmic domain heterogeneity and functions of IgG Fc receptors in B-lymphocytes. Science 256:1808–1812
Benhamou M, Bonnerot C, Fridman WH, Daëron M (1990) Molecular heterogeneity of murine mast cell Fcγ receptors. J Immunol 144:3071–3077
Biassoni R, Cantoni C, Falco M, Verdiani S, Bottino C, Vitale M, Conte R, Poggi A, Moretta A, Moretta L (1996) The human leukocyte antigen (HLA)-C-specific “activatory” or “inhibitory” natural killer cell receptors display highly homologous extracellular domains, but differ in their transmembrane and intracytoplasmic portions. J Exp Med 183:645–650
Bikah G, Lynd FM, Aruffo AA, Ledbetter JA, Bondada S (1998) A role for CD5 in cognate interactions between T cells and B cells, and identification of a novel ligand for CD5. Int Immunol 10:1185–1196
Binstadt BA, Brumbaugh KM, Dick CJ, Scharenberg AM, Williams BL, Colonna M, Lanier LL, Kinet J-P, Abraham RT, Leibson PJ (1996) Sequential involvement of lck and SHP-1 with MHC-recognizing receptors on NK cells inhibits FcR-initiated tyrosine kinase activation. Immunity 5:629–638
Bléry M, Delon J, Trautmann A, Cambiaggi A, Olcese L, Biassoni R, Moretta L, Chavrier P, Moretta A, Daëron M, Vivier E (1997) Reconstituted killer-cell inhibitory receptors for MHC class I molecules control mast cell activation induced via immunoreceptor tyrosine-based activation motifs. J Biol Chem 272:8989–8996
Bléry M, Kubagawa H, Chen CC, Vely F, Cooper MD, Vivier E (1998) The paired Ig-like receptor PIR-B is an inhibitory receptor that recruits the protein-tyrosine phosphatase SHP-1. Proc Natl Acad Sci USA 95:2446–2451
Borrego F, Ulbrecht M, Weiss EH, Coligan JE, Brooks AG (1998) Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated cytotoxicity. J Exp Med 187:813–818
Braud VM, Allan DSJ, O’Callaghan CA, Söderström K, D’Andrea A, Ogg GS, Lazetic S, Young NT, Bell JI, Phillips JH, Lanier LL, McMichael AJ (1998) HLA-E binds to natural killer cell receptors CD94/NKG2 A, B and C. Nature 391:795–799
Brown MG, Scalzo AA, Matsumoto K, Yokoyama WM (1997) The natural killer cell gene complex: a genetic basis for understanding natural killer cell function and innate immunity. Immunol Rev 155:53–65
Bruhns P, Marchetti P, Fridman WH, Vivier E, Daëron M (1999) Differential roles of N-and C-terminal ITIMs during inhibition of cell activation by killer cell inhibitory receptors. J Immunol 162:3168–3175
Burshtyn DN, Long EO (1997) Regulation through inhibitory receptors: lessons from killer cells. Trends Cell Biol 7:473–479
Burshtyn DN, Scharenberg AM, Wagtmann N, Rajogopalan S, Berrada K, Yi T, Kinet J-P, Long EO (1996) Recruitment of tyrosine phosphatase HCP by the killer cell inhibitory receptor. Immunity 4:77–85
Burshtyn DN, Yang W, Yi T, Long EO (1997) A novel phosphotyrosine motif with a critical amino acid at position-2 for the SH2 domain-mediated activation of the tyrosine phosphatase SHP-1. J Biol Chem 272:13066–13072
Cambier JC (1995) Antigen and Fc Receptor signaling: The awesome power of the immunoreceptor tyrosine-based activation motif (ITAM). J Immunol 155:3281–3285
Campbell M-A, Klinman NR (1995) Phosphotyrosine-dependent association between CD22 and protein tyrosine phosphatase 1 C. Eur J Immunol 25:1573–1579
Castells MC, Wu X, Arm JP, Austen KF, Katz HR (1994) Cloning of the gp49B gene of the immunoglobulin superfamily and demonstration that one of its two products is an early-expressed mast cell surface protein originally described as gp49. J Biol Chem 269:8393–8401
Cella M, Döhring C, Samaridis J, Dessing M, Brockhaus M, Lanzavecchia A, Colonna M (1997) A novel inhibitory receptor (ILT3) expressed on monocytes, macrophages, and dendritic cells involved in antigen processing. J Exp Med 185:1743–1751
Colonna M (1997) Immunoglobulin-superfamily inhibitory receptors: from natural killer cells to antigen-presenting cells. Research Immunol 148:168–171
Colonna M, Navarro F, Bellon T, Llano M, Garcia P, Samaridis J, Angman L, Cella M, Lopez-Botet M (1997) A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells. J Exp Med 186:1809–1818
Colonna M, Samaridis J (1995) Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells. Science 268:405–408
Cosman D, Fanger N, Borges L, Kubin M, Chin W, Peterson L, Hsu ML (1997) A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules. Immunity 7:273–282
D’Ambrosio D, Hippen KH, Minskoff SA, Mellman I, Pani G, Siminovitch KA, Cambier JC (1995) Recruitment and activation of PTP1 C in negative regulation of antigen receptor signaling by FcγRHBl. Science 268:293–296
Daëron M, Latour S, Malbec O, Espinosa E, Pina P, Pasmans S, Fridman WH (1995a) The same tyrosine-based inhibition motif, in the intracytoplasmic domain of FcγRIIB, regulates negatively BCR-, TCR-, and FcR-dependent cell activation. Immunity 3:635–646
Daëron M, Malbec O, Latour S, Aroc M, Fridman WH (1995b) Regulation of high-affinity IgE receptor-mediated mast cell activation by murine low-affinity IgG receptors. J Clin Invest 95:577–585
Engel P, Wagner N, Miller A, Tedder TF (1995) Identification of the ligand-binding domains of CD22, a member of the immunoglobulin superfamily that uniquely binds a sialic acid-dependent ligand. J Exp Med 181:1581–1586
Fong DC, Malbec O, Arock M, Cambier JC, Fridman WH, Daëron M (1996) Selective in vivo recruitment of the phosphatidylinositol phosphatase SHIP by phosphorylated FcγRIIB during negative regulation of IgE-dependent mouse mast cell activation. Immunol Letters 54:83–91
Fujioka Y, Matozaki T, Noguchi T, Iwamatsu A, Yamao T, Takahashi N, Tsuda M, Takada T, Kasuga M (1996) A novel membrane glycoprotein, SHPS-1, that binds the SH2-domain-containing protein tyrosine phosphatase SHP-2 in response to mitogens and cell adhesion. Mol Cell Biol 16:6887–6899
Gupta N, Scharenberg AM, Burshtyn DN, Wagtmann N, Lioubin MN, Rohrschneider LR, Kinet JP, Long EO (1997) Negative signaling pathways of the killer cell inhibitory receptor and Fc gamma RIIbl require distinct phosphatases. J Exp Med 186:473–478
Guthmann MD, Tal M, Pecht I (1995) A secretion inhibitory signal transduction molecule on mast cells is another C-type lectin. Proc Natl Acad Sci USA 92:9397–9401
Hinoda Y, Neumaier M, Hefta SA, Drzeniek Z, Wagener C, Shively L, Hefta LJ, Shively JE, Paxton RJ (1988) Molecular cloning of a cDNA coding biliary glycoprotein I: primary structure of a glycoprotein immunologically crossreactive with carcinoembryonic antigen. Proc Natl Acad Sci USA 85:6959–6963
Houchins JP, Yabe T, McSherry C, Bach FH (1991) DNA sequence analysis of NKG2, a family of related cDNA clones encoding type II integral membrane proteins on human natural killer cells. J Exp Med 173:1017–1020
Huber M, Helgason CD, Damen JE, Liu L, Humphries RK, Krystal G (1998) The sre homology 2-containing inositol phosphatase (SHIP) is the gatekeeper of mast cell degranulation. Proc Natl Acad Sci USA 95:11330–11335
Hulett MD, Hogarth PM (1994) Molecular basis of Fc Receptor function. Adv Immunol 57:1–127
Katz HR, Vivier E, Castells MC, McCormick MJ, Chambers JM, Austen KF (1996) Mouse mast cell gp49Bl contains two immunoreceptor tyrosine-based inhibition motifs and suppresses mast cell activation upon coligation with FcɛRI. Proc Natl Acad Sci USA 93:10809–10814
Kharitonenkov A, Chen Z, Sures I, Wang H, Schilling J, Ullrich A (1997) A family of proteins that inhibit signalling through tyrosine kinase receptors. Nature 386:181–186
Klingmüller U, Lorenz U, Cantley LC, Neel BG, Lodish HF (1995) Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of Jak2 and termination of proliferative signals. Cell 80:729–738
Kubagawa H, Burrows PD, Cooper MD (1997) A novel pair of immunoglobulin-like receptors expressed by B cells and myeloid cells. Proc Natl Acad Sci USA 94:5261–5266
Kuroiwa A, Yamashita Y, Inui M, Yuasa T, Ono M, Nagabukuro A, Matsuda Y, Takai T (1998) Association of tyrosine phosphatases SHP-1 and SHP-2, inositol 5-phosphatase SHIP with gp49Bl, and chromosomal assignment of the gene. J Biol Chem 273:1070–1074
Lanier LL, Corliss B, Wu J, Phillips JH (1998a) Association of DAP-12 with activating CD94/NKG2 C NK cell receptors. Immunity 8:693–701
Lanier LL, Corliss BC, Wu J, Leong C, Phillips JH (1998b) Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells. Nature 391:703–707
Latour S, Fridman WH, Daëron M (1996) Identification, molecular cloning, biological properties and tissue distribution of a novel isoform of murine low-affinity IgG receptor homologous to human FcγRIIBl. J Immunol 157:189–197
Law C-L, Sidorenko SP, Chandra KA, Zhao Z, Shen S-H, Fischer EH, Clark AA (1996) CD22 associates with protein tyrosine phosphatase 1 C, syk and phospholipase C-γl upon B cell activation. J Exp Med 183:547–560
Lazetic S, Chang C, Houchins JP, Lanier LL, Phillips JH (1996) Human natural killer cell receptors involved in MHC class I recognition are disulfide-linked heterodimers of CD94 and NKG2 subunits. J Immunol 157:4741–4745
Le Drean E, Vély F, Olcese L, Cambiaggi A, Guia S, Krysta G, Gervois N, Moretta A, Jotereau F, Vivier E (1998) Inhibition of antigen-induced T cell response and antibody-induced NK cell cytotoxicity by NKG2 A: association of NKG2 A with SHP-1 and SHP-2 protein-tyrosine phosphatases. Eur J Immunol 28:264–276
Maeda A, Kurosaki M, Kurosaki T (1998) Paired immunoglobulin-like receptor (PIR)-A is involved in activating mast cells through its association with Fc receptor gamma chain. J Exp Med 188:991–995
Malbec O, Fong D, Turner M, Tybulewicz VLJ, Cambier JC, Fridman WH, Daëron M (1998) FcɛRI-associated lyn-dependent phosphorylation of FcγRIIB during negative regulation of mast cell activation. J Immunol 160:1647–1658
Malbec O, Fridman WH, Daëron M (1999) Negative regulation of c-kit-mediated cell proliferation by FcγRIIB. J Immunol 162:4424–4429
Meyaard L, Adema G, Chang C, Woollatt E, Sutherland GR, Lanier LL, Phillips JH (1997) LAIR-1, a novel inhibitory receptor expressed on human mononuclear leukocytes. Immunity 7:283–290
Moretta A, Biassoni R, Bottino C, Pende D, Vitale M, Poggi A, Mingari MC, Moretta L (1997) Major histocompatibility complex class I-specific receptors on human natural killer and T lymphocytes. Immunol Rev 155:105–117
Muta T, Kurosaki T, Misulovin Z, Sanchez M, Nussenzweig MC, Ravetch JV (1994) A 13-amino-acid motif in the cytoplasmic domain of FcγRIIB modulates B-cell receptor signalling. Nature 368:70–73
Nakajima H, Samaridis J, Angman L, Colonna U (1999) Human Myeloid cells express an activating ILT receptor (ILT-1) that associates with Fc receptor gamma chain. J Immunol 162:5–8
Nishimura H, Nagahiro M, Nakano T, Honjo T (1998) Immunological studies on PD-1-deficient mice: implication of PD-1 as a negative regulator for B cell responses. Int Immunol 10:1563–1572
Olcese L, Cambiaggi A, Semenzato G, Bottino C, Moretta A, Vivier E (1997) Human killer cell activatory receptors for MHC class I molecules are included in a multimeric complex expressed by natural killer cells. J Immunol 158:5083–5086
Olcese L, Lang P, Vély F, Cambiaggi A, Marguet D, Bléry M, Hippen KL, Biassoni R, Moretta A, Moretta L, Cambier JC, Vivier E (1996) Human and mouse killer-cell inhibitory receptors recruit PTP1 C and PTP1D protein tyrosine phosphatases. J Immunol 156:4531–4534
Ono M, Bolland S, Tempst P, Ravetch JV (1996) Role of the inositol phosphatase SHIP in negative regulation of the immune system by the receptor FcγRIIB. Nature 383:263–266
Ono M, Okada H, Bolland S, Yanagi S, Kurosaki T, Ravetch JV (1997) Deletion of SHIP or SHP-1 reveals two distinct pathways for inhibitory signaling. Cell 90:293–301
Pessino A, Sivori S, Bottino C, Malaspina A, Morelli L, Moretta L, Biassoni R, Moretta A (1998) Molecular Cloning of NKp46: A novel member of the immunoglobulin superfamily involved in triggering of natural cytotoxicity. J Exp Med 188:953–960
Qiu WQ, de Bruin D, Brownstein BH, Pearse R, Ravetch JV (1990) Organization of the human and mouse low-affinity FcγR genes: duplication and recombination. Science 248:732–735
Renard V, Cambiaggi A, Vely F, Blery M, Olcese L, Olivero S, Bouchet M, Vivier E (1997) Transduction of cytotoxic signals in natural killer cells: a general model of fine tuning between activatory and inhibitory pathways in lymphocytes. [Review] [153 refs]. Immunol Rev 155:205–221
Reth MG (1989) Antigen receptor tail clue. Nature 338:383–384
Sato S, Miller AS, Inaoki M, Bock CB, Jansen PJ, Tang MLK, Tedder TF (1996) CD22 is both a positive and negative regulator of B lymphocyte antigen receptor signal transduction: Altered signaling in CD22-deficient mice. Immunity 5:551–562
Selvakumar A, Steffens U, Dupont B (1997) Polymorphism and domain variability of human killer cell inhibitory receptors. Immunol Rev 155:183–196
Smith KM, Wu J, Bakker ABH, Phillips JH, Lanier LL (1998) Ly-49D and Ly-49H associate with mouse DAP 12 and form activating receptors. J Immunol 161:7–10
Takei F, Brennab J, Mager, DL (1997) The Ly-49 family: genes, proteins, and recognition of class I MHC. Immunol Rev 155:67–78
Valiante NM, Phillips JH, Lanier LL, Parham P (1996) Killer cell inhibitory receptor recognition of human leukocyte antigen (HLA) class I blocks formation of a pp36/PLC-signaling complex in human natural killer (NK) Cells. J Exp Med 184:2243–2250
Vance RE, Kraft JR, Altaian JD, Jensen PE, Raulet DH (1998) Mouse CD94/NKG2 A is a natural killer cell receptor for the nonclassical major histocompatibility complex (MHC) class I molecule Qa-1. J Exp Med 188:1841–1848
Vély F, Olivero S, Olcese L, Moretta A, Damen JE, Liu L, Krystal G, Cambier JC, Daëron M, Vivier E (1997) Differential association of phosphatases with hematopoietic coreceptors bearing immunoreceptor tyrosine-based inhibition motifs. Eur J Immunol 27:1994–2000
Vély F, Vivier E (1997) Conservation of structural features reveals the existence of a large family of inhibitory cell surface receptors and noninhibitory/activatory counterparts. J Immunol 159:2075–2077
Vivier E, Daëron M (1997) Immunoreceptor tyrosine-based inhibition motifs. Immunol Today 18: 286–291
Wagtmann N, Biassoni R, Cantoni C, Verdiani S, Malnati M, Vitale M, Bottino C, Moretta L, Moretta A, Long EO (1995) Molecular clones of p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra-and the intracellular domains. Immunity 2:439–449
Wagtmann N, Rojo S, Eichler E, Mohrenweiser H, Long EO (1997) A new human gene complex encoding the killer cell inhibitory receptors and related monocyte/macrophage receptors. Curr Biol 8:1009–1017
Wang LL, Mehta IK, LeBlanc PA, Yokoyama WM (1997) Mouse natural killer cells express gp49Bl, a structural homologue of human killer cell inhibitory receptors. J Immunol 158:13–17
Withmueller U, Kurosaki T, Murakami MS, Ravetch JV (1992) Signal transduction by FcγRIII (CD16) is mediated through the γ chain. J Exp Med 175:1381–1390
Wu Y, Nadler MJS, Brennan LA, Gish GD, Timms JF, Fusaki N, Jongstra-Bilen J, Tada N, Pawson T, Wither J, Neel BG, Hozumi N (1998) The B-cell transmembrane protein CD72 binds to and is an in vivo substrate of the protein tyrosine phosphatase SHP-1. Curr Biol 8:1009–1017
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Daëron, M., Vivier, E. (1999). Biology of Immunoreceptor Tyrosine-based Inhibition Motif-Bearing Molecules. In: Daëron, M., Vivier, E. (eds) Immunoreceptor Tyrosine-based Inhibition Motifs. Current Topics in Microbiology and Immunology, vol 244. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-58537-1_1
Download citation
DOI: https://doi.org/10.1007/978-3-642-58537-1_1
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-63634-9
Online ISBN: 978-3-642-58537-1
eBook Packages: Springer Book Archive